Scientific Investigator – Oligonucleotide Therapeutics
We are seeking a highly skilled and experienced Scientific Investigator to join our team of scientists with the JAX Rare Disease Translational Center (RDTC) This role will be the lead technical scientist in nucleic acid therapeutics design and development. The successful candidate will provide technical ...
Associate Scientist II/Senior Associate Scientist, Oligonucleotide Chemistry
Building on our founders’ Nobel-prize winning discoveries in RNA interference, Atalanta Therapeutics is developing novel branched siRNA therapeutics to treat severe neurological diseases at the root cause. With two active partnerships with large biopharmaceutical companies plus a robust and growing internal pipeline, Atalanta is poised ...
PhD Position in treatment-response fluid biomarkers for ASO treatments at the Hertie Insitute for Clinical Brain Research
The research division „Translational Genomics of Neurodegenerative Diseases“ of Prof. Synofzik is currently looking for a PhD student for 3 years (extension possible) - position available immediately. About us Our division focuses on genomics, pathophysiology and translational biomarker research in the field of neurodegenerative diseases, ...
Biosensor Research Scientist
About the Role As a Biosensor Research Scientist, you will be an integral part of our R&D team, which primarily focuses on the development of point-of-care electrochemical aptamer-based sensors (E-AB) for drug monitoring and various other applications. You will focus on the construction techniques of ...
Chemist – Oligonucleotides
Sony Biotechnology Inc., supplies advanced flow cytometry analysis and sorting technology for use in life science research. To learn more: https://www.sonybiotechnology.com/us/. POSITION SUMMARY The Oligonucleotides Chemist is responsible for research scale-up and manufacturing operations with scientific expertise to ensure successful transfer of new products from development ...
Senior Scientist I/II – PK/PD, Neuroscience Biology
COMPANY DESCRIPTION: Building on our founders’ Nobel-prize winning discoveries in RNA interference, Atalanta Therapeutics is developing novel branched siRNA therapeutics to treat severe neurological diseases at the root cause. With two active partnerships with large biopharmaceutical companies plus a robust internal pipeline, Atalanta is poised ...
